The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
- 2024-05-16
- RCT · n = 25
- BMC complementary medicine and therapies 24(1)
- Parisa Ghanbari
- Davoud Raiesi
- Roghayeh Alboebadi
- Ahmad Zarejavid
- Mostafa Dianati
- Hamidreza Razmi
- Hadi Bazyar
- PubMed: 38755622
- DOI: 10.1186/s12906-024-04477-3
- High evidence
- Clinical
insulin, HOMA-IR, TC, TG, LDL-c, ALT, AST, AST/ALT, SBP, DBP and MAP decreased and QUICKi and HDL-c increased significantly (p-value for all < 0.05)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 520 mg/day